英文别名Everolimus Impurity 3; Everolimus Retroaldol Degradation Product; Everolimus Open-Ring Impurity; Everolimus Open-Ring Aldehyde Impurity; Everolimus Impurity 012-99; Everolimus Impurity 2; (2R,3S,6R,7E)-1-[(1S,3R,4R)-4-(2-Hydroxyethoxy)-3-methoxycyclohexyl]-2,6,8-trimethyl-5,9-dioxo-7-nonen-3-yl (2S)-1-[{(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrien-1-yl]-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl}(oxo)acetyl]-2-piperidinecarboxylate; [(E,2R,3S,6R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl] (2S)-1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trienyl]-2-hydroxy-3-methyloxan-2-yl]-2-oxoacetyl]piperidine-2-carboxylate 
